Related references
Note: Only part of the references are listed.Changes in chemotherapy-induced peripheral neuropathy, disturbance in activities of daily living, and depression following chemotherapy in patients with colorectal cancer: A prospective study
Pok-Ja Oh et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2020)
Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy A cross-sectional study
Hsin-Tien Hsu et al.
MEDICINE (2020)
Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy
Fiona Yeo et al.
SUPPORTIVE CARE IN CANCER (2019)
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer The ACHIEVE Phase 3 Randomized Clinical Trial
Takayuki Yoshino et al.
JAMA ONCOLOGY (2019)
Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy
L. M. Soveri et al.
ACTA ONCOLOGICA (2019)
Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer A Systematic Review and Meta-analysis
Devon J. Boyne et al.
JAMA NETWORK OPEN (2019)
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial
Robert Knoerl et al.
JOURNAL OF PAIN (2018)
The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study
Felice N. van Erning et al.
CLINICAL COLORECTAL CANCER (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population
Floortje Mols et al.
EUROPEAN JOURNAL OF CANCER (2016)
Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel
Lise Ventzel et al.
PAIN (2016)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
Marta Seretny et al.
PAIN (2014)
Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
Floortje Mols et al.
SUPPORTIVE CARE IN CANCER (2014)
Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2-to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry
Floortje Mols et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors
Cindy Tofthagen et al.
SUPPORTIVE CARE IN CANCER (2013)
The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts
Lonneke V. van de Poll-Franse et al.
EUROPEAN JOURNAL OF CANCER (2011)
Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Kim Cocks et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies
Gerardo Gutierrez-Gutierrez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
Guido Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2010)
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07
Stephanie R. Land et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
TJ Postma et al.
EUROPEAN JOURNAL OF CANCER (2005)
The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research
O Sangha et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Share Paper
